from all other diseases. A CD4/CD8 ratio of less than 1:1 has a 100 percent negative predictive value to exclude the diagnosis of sarcoidosis. Finding 1 percent or less neutro philsin BALhadan 80 percentpositivepredictivevalue in distinguishing sarcoidosis from nonsarcoidosis RD and 51 percent for distinguishing sarcoidosis from all other disease groups. The CD4/CD8 ratio and the percentages of neutro phils and eosinophils also were combined and analyzed for the diagnosisof sarcoidosis. 
pneumonitis. To date no clinical study has carefully evaluated the use of BALF lym phocyte subgroups and granulocyte populations in distinguishing sarcoidosis from diseases capable of mimicking sarcoidosis in a large control group. The present study examines the diagnostic specificity of BALF cell populations (percentages of lymphocytes, B lymphocytes, and T lymphocytes, CD4/CD8 ratios, and percentages of neutrophils and eosinophils) in recognizing pulmonary sarcoidosis and compares the diagnostic accuracy of BALF cell analysis with that of the presence of multiple noncaseating granuloma (MNG) in a simultaneous transbronchial biopsy (Tbbx) specimen as an indicator of pulmonary sarcoidosis.
Study Population
performed in the area lavaged. Four or more specimens were obtained from each patient.
Bronchoalveolar Lavage Fluid Cell Analysis
The volume of the BAL return was recorded and a small aliquot of fluid taken for estimation of cell viability by Trypan blue dye exclusion. A hemocytometer chamber count was performed to determinethe total numberof nucleatedcellsin the BALF. The 
Statistical Analysis
One-way analysis of variance and the Kruskal-Wallis test were performed to analyze for differences in cell populations among different diagnostic groups. The Bonferroni t test was used to further locatedifferencesbetween specificgroups.A p@O.05value was considered significant. Sensitivity specificity, positive predic live value, and negative predictive value were calculated to evaluate BALF cell populations as diagnosticcriteria for sarcoidosis. 
RESULTS

Diseases
Bronchoalveolar Lavage Technique
The technique for FOB, BAL, and Thbx is standard among the members of our Section of Pulmonary and Critical Care Medicine.
With topicallyadministered lidocaine(Xylocaine), boththe upper and lower respiratory tracts were anesthetized.The BF-P20Olym clinical diagnosis of IPF, including one in whom the diagnosis was confirmed at autopsy. Drug-induced ILD was diagnosed by exposure to a drug recognized as a cause of diffuse alveolar injury, reversal of the syndrome after the drug was discontinued (either with or without steroid therapy), absence of other recogniz able ILD, and no recurrence ofthe illness when there had been no re-exposure to the offending â€˜¿ Â°O nly one patient was knowingly rechallenged, and she developed a diffuse pulmonary infiltrate on re-expo sure to @ The four patients with collagen vascular associated ILD included three with rheuma toid arthritis and one with dermatomyositis.
The four patients with radiation pneumonitis all had bronchogenic carcinoma treated with x-ray therapy. Fever, cough, dyspnea, and a new roentgenographic infiltrate in the irradiated field occurred in each. All had a negative search for infection including quanti tative cytologic brush culture, immunofluorescence for antibody-coated bacteria, and cultures for virus, mycobacteria, and fungi. All patients had roentgeno graphically evidenced or symptomatic improvement with cessation ofx-ray therapy or use ofcorticosteroids, or both. There was no recurrence of the illness when further radiotherapy was not administered.
The patients with BOOP and pseudolymphoma were diagnosed by open-lung biopsy. The patient with berylliosis had a history of beryllium exposure, gran uloma evidenced on Tbbx, and significant lung paren chyma beryllium content by radiodiffusion assay.
Infection or Organism Isolated: Twenty-two patients had pulmonary infections with the etiologic organism recovered at FOB. None of the patients had AIDS or neutropenia.
Nine patients had chronic bacterial @3Diagnostic criteria were as follows:
symptoms and roentgenographic abnormalities of more than one month's duration; (2) more than 4,000 colony-forming units of a single bacterial species on quantitative culture of a bronchoscopic brush speci men; (3) no clinical evidence of intrathoracic tumor, bronchiectasis, lung abscess, chronic bronchitis, for eign body, or immunodeficiency; 
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@ . IPF and two patients with irradiation pneumonitis had of variance showed a significant difference in the a CD4/CD8 ratio of 1:1 or less.
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percentages of neutrophils among diagnostic groups Percentages ofNeutrophiLs and EosinophiLs: Analysis (p = 0.002 [Fig 3] ). The percentages of neutrophils in Table 3 lists Table 4 combines the BALF CD4/CD8 ratio, per centage of neutrophils, and a value of 1 percent or less for eosinophils in the diagnosis of sarcoidosis. Using criteria of a CD4/CD8 ratio of 2:1 or more, 1 percent or less neutrophils, and 1 percent or less eosinophils in BALF to recognize sarcoidosis yielded a sensitivity of 59 percent, specificity of 94 percent, positive predictive value of73 percent, and a negative predictive value of 90 percent in distinguishing sar coidosis from all other diseases. Thus, of those who met the criteria, 73 percent had sarcoidosis, while of those failing the criteria, 90 percent were nonsarcoi dosis patients and 10 percent had sarcoidosis. The positive predictive value for these criteria rose to 89 percent in comparing sarcoidosis with nonsarcoidosis ILD (Table 4) . Changing the criteria to a CD4/CD8 ratio of4:1 or more, 1 percent or less neutrophils, and 1 percent or less eosinophils increases the positive predictive value of 80 percent for separation of sar coidosis from all other diseases and 92 percent versus nonsarcoidosis ILD but decreases the sensitivity for sarcoidosis to 44 percent (Table 4) (Table 4) . However, criteria ofa CD4/CD8 ratio of 1:1 or more, 1 percent or less neutrophils, and 1 percent or less eosinophils had a sensitivity of 74 percent, a specificity of 93 percent, a positive predic tive value of9l percent, and negative predictive value of 79 percent in distinguishing sarcoid from nonsar coidosis ILD. 
Predictive Value of CD4/CD8 Ratio and Percentages ofNeutrophils and EosinophiLc in Diagnosing Sarcoidosis
Demonstration of Granulomas in Transbronchial
DISCUSSION
In 1981, Crystal and colleagues9 stated that â€oe¿ other than sarcoidosis, the only lung disorders known to be associated with increased proportions of lymphocytes in lavage are hypersensitivity pneumonitis, tubercu The present study is the first effort to use a combina tion ofCD4/CD8 ratio and percentages of neutrophils and eosinophils determined by BALF analysis to develop diagnostic criteria for sarcoidosis. The sarcoid osis population was compared with both 28 patients with nonsarcoidosis ILD and 73 patients with other diagnoses which at times present with a clinical picture similar to sarcoidosis. Only nine of the latter had a diffuse roentgenographic abnormality similar to sar coidosis. However, mycobacterial, ftmgal and viral infection, lymphangitic or hematogenously spread car cinoma, and leukemic or lymphomatous pulmonary involvement can at times mimic the roentgenographic appearance of sarcoidosis. It seemed important to us that diseases other than nonsarcoidosis ILD be in cluded in the control group and diagnostic criteria be developed to distinguish these entities from sarcoid osis. In general, BALF cell populations were more precise in distinguishing sarcoidosis from nonsarcoi dosis ILD than from infection, inflammation, neo plasm, and bronchial hyperreactivity. Table 5 However, a CD4/CD8 ratio of 4:1 or more alone was only 84 percent specific in distinguishing sarcoidosis from all other diseases. Only 50 percent of patients meeting the criteria had sarcoidosis. Pulmonary infec tion, inflammation, and neoplasms not infrequently have a CD4/CD8 ratio of 4:1 or more, but more than 1 percent neutrophils, and more than 1 percent eosinophils. Thus, the combination of a CD4/CD8 ratio of2:1 or more, 1 percent or less neutrophils, and 1 percent or less eosinophils is superior to a CD4/ CD8 ratio as a single criterion in distinguishing sarcoidosis from these disease groups.
None of our sarcoidosis patients had a CD4JCD8 ratio ofless than 1:1, consequently, this single criterion had a 100 percent negative predictive value in exclud ing sarcoidosis from both nonsarcoidosis ILD and all other disease groups. Exceptions will almost certainly exist, but they will probably be rare. For example, Robinson and colleagues2Â°found a CD4JCD8 ratio of less than 1:1 in 1 of their 20 patients with sarcoidosis.
Clinicians must be aware of several caveats in adopting our results for their practice. First, it must be emphasized that our criteria were developed from patients with 16 percent or more lymphocytes in the BALF. In this study, 6 (18 percent) of33 patients with sarcoidosis had 16 percent or less lymphocytes. Chre tien and colleagues's found 15 percent or less lympho cytes in 32 percent of their patients with sarcoidosis. It is unknown whether BALF cell patterns in this group would be similar to those of sarcoidosis patients with 16 percent or more lymphocytes. A second caveat is to be constantly aware of the denominator used to calculate percentages of differential cell counts.@ We elected to count neutrophils, lymphocytes, eosino phils, basophils, alveolar macrophages, bronchial epi thelial, and squamous epithelial cells, creating a de nominator of total nucleated cells.@ From these data, we have recalculated the percentages of differential cell counts, predictive values, sensitivities, and speci ficities in Tables 3 and 4 
